Jérôme Bertherat Selected Research

Jérôme Bertherat Research Topics

Disease

80	Neoplasms (Cancer) 01/2024 - 01/2002
56	Cushing Syndrome 01/2024 - 05/2002
31	Hyperplasia 11/2023 - 05/2002
24	Adrenocortical Carcinoma 05/2023 - 08/2003
24	Adenoma (Adenomas) 01/2022 - 05/2002
17	Pituitary ACTH Hypersecretion 12/2022 - 01/2004
16	Pheochromocytoma 01/2022 - 03/2006
16	Paraganglioma (Paragangliomas) 01/2022 - 03/2006
12	Adrenocortical Adenoma (Disease, Conn's) 01/2021 - 08/2003
12	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2018 - 11/2002
11	Carney Complex 11/2020 - 12/2002
11	Carcinogenesis 12/2012 - 12/2002
9	Acth-Independent Macronodular Adrenal Hyperplasia 11/2013 - 05/2002
7	Adrenal Insufficiency (Adrenal Gland Hypofunction) 11/2023 - 05/2008
5	Hypertension (High Blood Pressure) 01/2022 - 03/2009
4	Carcinoma (Carcinomatosis) 12/2018 - 03/2005
3	Pituitary Neoplasms (Pituitary Adenoma) 12/2023 - 01/2009
3	Headache (Headaches) 12/2023 - 08/2015
3	Acromegaly 12/2023 - 06/2006
3	ACTH-Secreting Pituitary Adenoma 01/2021 - 01/2009
3	Myxoma (Myxomas) 11/2020 - 05/2006
3	Hyperaldosteronism (Conn Syndrome) 09/2020 - 02/2014
3	Adrenal Gland Neoplasms (Adrenal Cancer) 01/2018 - 08/2003
3	Neoplasm Metastasis (Metastasis) 01/2017 - 06/2004
2	Erectile Dysfunction 12/2023 - 07/2012
2	Adrenal incidentaloma 11/2023 - 03/2007
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2023 - 01/2021
2	Hypoglycemia (Reactive Hypoglycemia) 02/2023 - 02/2018
2	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 03/2022 - 11/2019
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2006
2	Prolactinoma (Prolactinomas) 01/2022 - 08/2020
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2019 - 06/2013
2	Addison Disease (Addison's Disease) 02/2018 - 12/2017
2	Disease Progression 01/2016 - 03/2007
2	Hypogonadism (Hypergonadotropic Hypogonadism) 05/2013 - 01/2013
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2011 - 12/2010
2	Beckwith-Wiedemann Syndrome (Exomphalos Macroglossia Gigantism Syndrome) 11/2006 - 10/2005

Drug/Important Bio-Agent (IBA)

41	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2024 - 05/2002
33	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2023 - 05/2002
15	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2002
14	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 03/2005
14	SteroidsIBA 08/2022 - 01/2002
14	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2020 - 12/2002
12	GlucocorticoidsIBA 08/2022 - 05/2008
10	EnzymesIBA 08/2022 - 03/2005
8	Mitotane (Lysodren)FDA Link 12/2018 - 07/2006
8	Succinate Dehydrogenase (Fumarate Reductase)IBA 06/2015 - 03/2006
8	CateninsIBA 06/2015 - 11/2010
7	CatecholaminesIBA 01/2022 - 01/2002
7	Messenger RNA (mRNA)IBA 01/2018 - 12/2002
7	Cyclic AMP (AMP, Cyclic)IBA 09/2009 - 01/2002
6	Hormones (Hormone)IBA 12/2023 - 11/2002
6	AldosteroneIBA 01/2021 - 06/2004
6	beta CateninIBA 01/2021 - 09/2005
6	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2018 - 01/2002
6	Peptides (Polypeptides)IBA 01/2017 - 03/2006
5	OsilodrostatIBA 06/2023 - 05/2021
5	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2013 - 07/2006
4	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022 - 10/2009
4	gastric inhibitory polypeptide receptorIBA 01/2022 - 05/2002
4	Carrier Proteins (Binding Protein)IBA 07/2012 - 11/2002
3	AndrogensIBA 08/2022 - 07/2006
3	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 08/2022 - 01/2010
3	Protein Isoforms (Isoforms)IBA 01/2019 - 05/2002
3	Serotonin (5 Hydroxytryptamine)IBA 09/2016 - 11/2006
3	MetanephrineIBA 01/2016 - 10/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 01/2017
2	ProlactinIBA 12/2023 - 07/2007
2	Metyrapone FDA Link 05/2023 - 08/2022
2	Insulin (Novolin)FDA Link 02/2023 - 02/2018
2	Testosterone (Sustanon)FDA Link 12/2022 - 07/2012
2	MineralocorticoidsIBA 08/2022 - 02/2018
2	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 08/2022 - 09/2020
2	ParaffinIBA 04/2022 - 08/2015
2	LipidsIBA 01/2022 - 09/2015
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2022 - 08/2020
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2019
2	P-2 (P 2)IBA 01/2019 - 03/2009
2	Etoposide (VP 16)FDA LinkGeneric 12/2018 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2018 - 01/2006
2	Steroidogenic Factor 1IBA 01/2017 - 02/2012
2	NormetanephrineIBA 01/2016 - 05/2012
2	Progesterone FDA LinkGeneric 12/2015 - 06/2008
2	pasireotideIBA 10/2015 - 01/2012
2	Insulin-Like PeptidesIBA 01/2014 - 11/2006
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2010 - 01/2003
2	LigandsIBA 09/2010 - 03/2009
2	Metoclopramide (Reglan)FDA LinkGeneric 03/2009 - 01/2003
2	aryl hydrocarbon receptor-interacting proteinIBA 01/2009 - 07/2007
2	Adenosine (Adenocard)FDA LinkGeneric 10/2008 - 08/2003
2	Phosphotransferases (Kinase)IBA 05/2008 - 07/2003
2	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 11/2006 - 03/2005
2	ElementsIBA 07/2006 - 08/2003

Therapy/Procedure

15	Therapeutics 01/2024 - 09/2005
14	Adrenalectomy 05/2023 - 01/2004
3	Drug Therapy (Chemotherapy) 12/2018 - 03/2007
2	Pancreatectomy 12/2019 - 10/2019
2	Ligation 01/2017 - 01/2013
2	Pituitary Irradiation 04/2011 - 01/2007